Last Updated : February 3, 2014
Details
FilesGeneric Name:
Indacaterol/glycopyrronium
Project Status:
Complete
Therapeutic Area:
Chronic obstructive pulmonary disease
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Call for patient/clinician input open:
Brand Name:
Ultibro Breezhaler
Project Line:
Reimbursement Review
Project Number:
SR0369-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
COPD
Recommendation Type:
List with criteria/condition
Final Recommendation:
Files
Last Updated : February 3, 2014